TEN STUDIES AND COMMENTS ON HCQ AND COVID-19

What do the scientists who treat patients, those from Harvard and Yale, say about HCQ and COVID-19?

Early studies failing HCQ were flawed:

• The Mehra study in Lancet was retracted due to false data.
• The RECOVERY study used 2400 mg HCQ (toxic doses). 6x the normal dose.
• The Borba Study used 1200 mg CQ (toxic dose), 8x the normal dose.
• The Boulware study did not confirm most of their cases with PCR testing making the results unreliable. 
• The infamous Magagnoli V.A. Study could use one dose of HCQ late in the disease, even hours before death, to claim HCQ failed; it used no matched control group.They only  studied 384 people.

Recent Controlled Studies finding success with HCQ:

• Henry Ford looked at 2,500 patients and used normal, (not toxic) doses of HCQ. They treated early, 91% got their first dose within 48 hours of admission. They received a 5 day course of treatment. Despite being sicker the HCQ group had only a 13%  death rate, while the control non-HCQ group had a 26% death rate. 
• Scholtz, Derwand, and Zelenko tested outpatients using normal doses of HCQ (not toxic). They were treated with 5 days of HCQ starting early, usually within 4 days of onset of symptoms. They enrolled 335 positive COVID-19 patients - all confirmed with PCR testing - 127 were treated with the Triple Therapy of HCQ, ZINC, and Azithromycin, while 208 patients were not treated with HCQ. The treated group was hospitalized 84 % less than controls. The treated group died 80% less than controls. 
• NYU Carlucci found a 50% reduction in death with  HCQ.
• Chatterjee working in India tested front-line health care workers. Those receiving weekly HCQ at normal (not toxic) doses enjoyed an 80% reduction in the chance of COVID-19 infection after six doses.

Rather than listen to Donald Trump or the media, or "experts" who speak but do not treat, maybe look at these studies. My words are based upon the analysis of Harvard and Yale experts, Dr. Harvey Risch of the Yale School of Public Health, and Dr. George Fareed, the Harvard-trained 2015 Rural California Physician of the Year and treater of over 1,000 COVID-19 patients with HCQ - with excellent results.

It's all in my new book, "Surviving Cancer, COVID-19, & Disease: The Repurposed Drug Revolution." 

It will most certainly impact your life, and it just might save it.

WWW.HOPEPRESSWORKS.ORG